You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Latvia

Feb 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Latvia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Latvia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Latvia for free:

The Consumer Health in Latvia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Latvia?
  • What are the major brands in Latvia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health returns to stability

In 2010, OTC and vitamins and dietary supplements value remained stable. This is positive since after the large contraction in 2009, 2010 was the first year of recovery and consumer health returned to its usual, stable position.

OTC sales recover slowly

Consumers on a limited budget prefer to spend money on prescription medicines rather than OTC products, so priority and price were important factors. Although the major downturn of the Latvian economy is finished, the purchasing power of consumers did not improve significantly. The additional income that people spent in 2010 was on prescription medicines, as consumers were careful to choose products which they believed were most important. Players implemented a number of discount measures, focusing on volume rather than value, allowing them to gain positive volume growth in 2010. They were therefore able to ensure customers continued to buy their products.

Competition increased during contraction in consumer health

As consumer health reduced and then slowly recovered, competition became more intense. Companies tried different tactics to compensate for their 2009 losses resulting in a stronger competitive environment. Well-established brands experienced share growth, while smaller brands and recent entries lost substantial share.

Chemists/pharmacies continues to dominate distribution channels

The medicines distribution law in Latvia did not change in 2010, and medicines can only be sold in chemists/pharmacies. In 2009 the Ministry of Health reviewed the growing tendency of self-serve pharmacies and decided not to have regulations that make a pharmacist consultation mandatory for all types of medicines. This decision received heavy criticism from the industry. Many noted that this government policy disturbs the market and is controversial, particularly as the Ministry did not change its policy towards internet OTC retailing. Internet retailing grew since 2009 in terms of the number of online shops and the variety of products available.

Consumer health is expected to recover during the forecast period

Consumer health is expected to recover well between 2010-2015. Due to specific demographic conditions in Latvia, most categories do not have room for growth. There was a sharp volume recovery in 2010 which is expected to reach the historically high 2008 levels by 2011. However, the total value will change as the Latvian standard of living changes. Recovery will therefore strongly depend on the ability of the Latvian economy to recover.

Table of Contents

Table of Contents

Consumer Health in Latvia - Industry Overview

EXECUTIVE SUMMARY

Consumer health returns to stability

OTC sales recover slowly

Competition increased during contraction in consumer health

Chemists/pharmacies continues to dominate distribution channels

Consumer health is expected to recover during the forecast period

KEY TRENDS AND DEVELOPMENTS

Reducing prices to increase sales

International brand dominance

Ageing population will lead to a change in consumer health dynamics

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Latvia - Company Profiles

Grindeks AS - Consumer Health - Latvia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Grindeks: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 6 Grindeks: Competitive Position 2010

Olainfarm AS - Consumer Health - Latvia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Olainfarm: Competitive Position 2010

Silvanols Ltd - Consumer Health - Latvia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Silvanols: Competitive Position 2010

Adult Mouth Care in Latvia - Category Analysis

HEADLINES

TRENDS

  • In 2010, adult mouth care was at its highest at LVL200,000. Nonetheless, it was small due to customer preference for cosmetic/everyday use adult mouth care products over medicated ones, which are primarily used in cases when it is advised by a professional dentist.

SWITCHES

COMPETITIVE LANDSCAPE

  • Arcam GmbH leads adult mouth care with a 36% share, due to its brand Lacalut. This is a well recognised brand and the company is working effectively with dentists to promote its products.

PROSPECTS

  • Adult mouth care is forecasted to grow by a 3% CAGR between 2010 and 2015 to reach LVL200,000.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Latvia - Category Analysis

HEADLINES

TRENDS

  • An increasing amount of consumers chose ibuprofen and combination products over acetaminophen in 2010. As a result, acetaminophen value reduced by less than 1% in 2010. However, it was still popular due to long established-consumer recognition and low price. It is not believed to be dangerous, nor are customers concerned that it has previously unknown health hazards. Customers turned away from acetaminophen because the other options were more appealing.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratoires UPSA had the biggest share of analgesics in 2010 with a 13% share, followed by Bayer AG with 10%. The product portfolio of both companies predominantly contains acetaminophen products. While Laboratoires UPSA's portfolio was split between Efferalgan and Upsarin with 6% and 7% respectively, Bayer's AG leading analgesics brand was Saridon with 5%. GlaxoSmithKline which is on the third place has achieved highest growth due to wider portfolio with leading brand Panadol.

PROSPECTS

  • In the forecast period of 2010-2015 analgesics value is predicted to grow by a constant value CAGR of 2%.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Latvia - Category Analysis

HEADLINES

TRENDS

  • In 2010 calming and sleeping products recovered after a decrease in growth of -9% in 2009 due to the switch of a major brand Corvalolum in 2008. It recovered quickly because of the high competition levels and the ability of the competitors to quickly take the share of the missing brand.

SWITCHES

COMPETITIVE LANDSCAPE

  • Farm AG SIA had the largest share in 2010 at 22% due to its main brand Validolum, which was the quickest to take over the share held by Corbvalolum. Validolum is a nerve system calming drug which is used by the main consumer group, the elderly, to prevent nerve and heart complications.

PROSPECTS

  • Calming and sleeping products is forecasted to reach LVL2 million in 2015 with a CAGR growth of 2% during the forecast period. This growth forecast is positive as the main factors that will contribute are the increasing elderly population in Latvia and the expansion into the middle age consumer group.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares 2006-2010
  • Table 26 Calming and Sleeping Brand Shares 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Latvia - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies growth slowed down due to the low number of influenza cases in 2010. Combination products performed worse than expected and its 2010 value reached only LVL5 million. Due to an unusually hot summer and sudden weather changes there was a high number of cases of colds and therefore a higher than expected demand for decongestants.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2010 Novartis AG leads with a value share of 13%, an increase of 1% from 2009. This company has been in Latvia for many years and has a great deal of customer recognition. Its portfolio consists of a number of different recognisable brands such as Theraflu, Vibrocil and Tavegyl.

PROSPECTS

  • During the forecast period cough, cold and allergy (hay fever) remedies is expected to grow by a constant value CAGR of 2% to reach a LVL13 million by 2015. The growth percentage was restated from the 2009 forecast, because the economy contraction in 2009 was bigger than predicted. However it is expected that full recovery after the 2009 economic downturn will occur by 2015.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Latvia - Category Analysis

HEADLINES

TRENDS

  • In 2010 digestive remedies reached LVL5 million, posting its second lowest ever growth of 1%. There were no special disease outbreaks that would have otherwise influenced digestive remedies, therefore prices followed the general trend of negligible growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • Berlin-Chemie/Menarini Baltic SIA remains the leading company in digestive remedies in 2010 with a 19% share. Its position is guaranteed by a number of well marketed and recognised brands such as Mezym Forte, Espumisan and Raniberl. The company’s share remained the same as in 2009. However, in terms of single brands, Rennie by Roche Holding AG, takes first place in 2010 with a 10% value share.

PROSPECTS

  • Future growth of digestive remedies will strongly depend on the growth of the Latvian economy and the dynamics of price fluctuations. Prospects are positive with a forecast growth of 2% in 2011 and an overall forecast period CAGR growth of 2%.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 37 Digestive Remedies Company Shares 2006-2010
  • Table 38 Digestive Remedies Brand Shares 2007-2010
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Latvia - Category Analysis

HEADLINES

TRENDS

  • OTC ear care in Latvia was small and reached LVL150,000 in 2010. This was due to the nature of ear care products, and also because Latvian consumers visit a doctor if they have an ear problem and either get prescription medicine or other form of help.

SWITCHES

COMPETITIVE LANDSCAPE

  • ICN Polfa Rzeszow SA led in 2010 with a 15% share. This was based on a single brand, Otinum, which are ear drops that treat most forms of ear inflammation and pain.

PROSPECTS

  • Ear care is forecasted to have a 2% CAGR growth between 2010 and 2015 which is good given its small size and varying demand.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2005-2010
  • Table 42 Sales of Ear Care: % Value Growth 2005-2010
  • Table 43 Ear Care Company Shares 2006-2010
  • Table 44 Ear Care Brand Shares 2007-2010
  • Table 45 Forecast Sales of Ear Care: Value 2010-2015
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Latvia - Category Analysis

HEADLINES

TRENDS

  • Emergency contraception grew by less than 1% in 2010. This was due to the stability of prices in 2010. Volume growth of emergency contraception remained unchanged.

COMPETITIVE LANDSCAPE

  • The leader and sole representative is Richter Gedeon Nyrt with a 100% value share. Until 2009 its only product was Postinor-2, however in 2009 the company introduced Escallepe which contains the same active ingredient but has a twice larger dose at 1.5mg.

PROSPECTS

  • Emergency contraception is forecasted to have a 2% CAGR growth between 2010 and 2015.

CATEGORY DATA

  • Table 47 Sales of Emergency Contraception: Value 2005-2010
  • Table 48 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 49 Emergency Contraception Company Shares 2006-2010
  • Table 50 Emergency Contraception Brand Shares 2007-2010
  • Table 51 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 52 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Latvia - Category Analysis

HEADLINES

TRENDS

  • Eye care in Latvia is of average size, with a 2% share of consumer health. Growth was 1% in 2010, which was lower than the review period CAGR of 3%. However, it did not change as much as other categories and remained at positive levels.

SWITCHES

COMPETITIVE LANDSCAPE

  • Santen Oy is the leading company in eye care in Latvia in 2010 with a 20% share. The company has a successful range of brands such as Olfagel with a 10% share, Artelac with 6% and Lecrolyn with 5%.

PROSPECTS

  • Eye care is forecasted to have a stable and good growth of 3% CAGR from 2010 to 2015, reaching LVL1 million by 2015.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2005-2010
  • Table 54 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 55 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 56 Eye Care Company Shares 2006-2010
  • Table 57 Eye Care Brand Shares 2007-2010
  • Table 58 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Latvia - Category Analysis

HEADLINES

TRENDS

  • The demand for the herbal/traditional medicines has been increasing during the last years, however it has been very unstable as it is composed of the subcategories from across the whole consumer healthcare market.

COMPETITIVE LANDSCAPE

  • Rigas Farmaceitiska Fabrika A/S led with a 15% value share in 2010. Most of its products are herbal and it has a wide portfolio of products. Sausa Mikstura Pret Klepu, Baldriana Tinktura and Fenhela Teja were the top three brands in 2010.

PROSPECTS

  • Herbal/traditional products is expected to grow by a CAGR of 2% over the forecast period. This growth is expected to follow the economic development in Latvia. The demand for herbal/traditional products will be stable because of a large and loyal consumer base.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 62 Herbal/Traditional Products Company Shares 2006-2010
  • Table 63 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Latvia - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care did not have any significant value changes in 2010. It continued to experience the effects of the economic turbulence that overwhelmed it in 2009. Price stability occurred because customers ran out of disposable income, and were very cautions with their spending in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • The Finnish company, Novartis AG, was the leader with a 14% share in 2010. Its success was driven by a single brand, Lamisil, which had an 11% share of medicated skin care. Lamisil, a topical antifungal remedy comes in four formats: spray, solution, cream and gel. It is widely available due to successful pharmacy networking methods and has a low price. In 2010 Novartis' share remained unchanged.

PROSPECTS

  • By 2015 medicated skin care in Latvia is expected to reach LVL2 million with a CAGR of 2% over the forecast period. While growth is expected to be positive, a 2% CAGR growth is not high and means that value will remain stable, and will only grow with the Latvian economy.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 68 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 69 Medicated Skin Care Brand Shares 2007-2010
  • Table 70 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 71 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Latvia - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids appeared in 2006 in Latvia. Demand for the products was due to consumers deciding to stop smoking. The market was not yet established in 2010 and was small, with less than 1% of total consumer health.

SWITCHES

COMPETITIVE LANDSCAPE

  • The market is dominated by Pharmacia & Upjohn consumer healthcare that controls 69% of the market with Novartis AG second with a 10% share. The company's success came from weak competition and high recognition of its brands, Nicorette 10mg plasters and Nicorette Freshmint.

PROSPECTS

  • NRT smoking cessation aids is expected to continue to grow over the forecast period with a CAGR of 5% to reach LVL300,000 by 2015.

CATEGORY INDICATORS

  • Table 72 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 73 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2010
  • Table 74 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2010
  • Table 75 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 76 NRT Smoking Cessation Aids Company Shares 2006-2010
  • Table 77 NRT Smoking Cessation Aids Brand Shares 2007-2010
  • Table 78 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 79 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Latvia - Category Analysis

HEADLINES

TRENDS

  • While sports are popular in Latvia, sports nutrition was mainly used by professionals. The trend of consumers of every age and type involved in sports to consume sports nutrition products started to intensify only when the economy was booming in Latvia. Advertising was a major factor determining this.

COMPETITIVE LANDSCAPE

  • Weider Global Nutrition LLC is the leading company in 2010 with a 28% value share. This German producer relies primarily on its protein powder brands CFM Whey Protein and Premium Whey Pro, but also had other types of products such as Mega Mass 2000 protein bars, and amino-acids CLA Weider. The key factors to the company's success are reliable distribution and partners who are able to connect to the sporting community.

PROSPECTS

  • Sports nutrition is expected to grow at a 4% CAGR to reach LVL1 million by 2015. This is a very good rate when compared to overall consumer health.

CATEGORY DATA

  • Summary 13 Sports Nutrition, category rankings 2010
  • Table 80 Sales of Sports Nutrition: Value 2005-2010
  • Table 81 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 82 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 83 Sports Nutrition Company Shares 2006-2010
  • Table 84 Sports Nutrition Brand Shares 2007-2010
  • Table 85 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 86 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Latvia - Category Analysis

HEADLINES

TRENDS

  • An increasing amount of vitamins and dietary supplements was available in the major grocery retailers such as Rimi and Maxima. This was important as it enabled the products to reach more consumers which will increase value sales. While most vitamins and dietary supplements were also available via the internet, the majority of consumers preferred store-based retailing.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Competition in vitamins and dietary supplements is very strong with numerous players. It has high value at LVL12 million, which is a 22% share of consumer health. Another reason for its strength is the difference in regulation from the medicines market. Vitamins and dietary supplements is not regulated by the Ministry of Health and SAM like other OTC products, but instead by the Product and Veterinary Department, therefore the rules and regulations are much simpler.

PROSPECTS

  • Vitamins and dietary supplements is expected to grow at a CAGR of 2% over the forecast period to reach LVL13 million by 2015. This is a better performance than the -3% growth during the review period and is in line with overall forecasted consumer health growth.

CATEGORY DATA

  • Summary 14 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 87 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 88 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 89 Dietary Supplements by Positioning 2006-2010
  • Table 90 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 91 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 92 Vitamins Brand Shares 2007-2010
  • Table 93 Dietary Supplements Brand Shares 2007-2010
  • Table 94 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 95 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Latvia - Category Analysis

HEADLINES

TRENDS

  • The traditional consumer groups were people with medical disorders caused by weight management and athletes. However an increasing amount of consumers from other groups such as adult women and men are now interested in these products since they became more self conscious about their weight and the possible future consequences of obesity.

COMPETITIVE LANDSCAPE

  • Aptiekas Produkcija SIA is the leader in weight management with a 20% value share. Its success is based on its weight loss supplements product, Phase 2. The product is a carbohydrate blocker and is recognised by consumers as one of the most functional solutions. The company also benefits from a wide distribution network across health food, sports nutrition and internet shops.

PROSPECTS

  • Weight management is expected to grow by a CAGR of 2% over the forecast period to reach a total value of LVL 2 million. This is a positive forecast compared to the rest of consumer health. However it is significantly smaller than the previous five years CAGR growth of 5%.

CATEGORY DATA

  • Table 96 Sales of Weight Management by Category: Value 2005-2010
  • Table 97 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 98 Weight Management Company Shares 2006-2010
  • Table 99 Weight Management Brand Shares 2007-2010
  • Table 100 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 101 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Latvia - Category Analysis

HEADLINES

TRENDS

  • Wound care reached sales of LVL1 million in 2010.

COMPETITIVE LANDSCAPE

  • SCA Molycke is the largest company with a 29% share. The company has a range of brands including Mepore and Mefix. Mepore is more expensive and is a surgical wound specific product while Mefix has a universal method of application. Both combine well to address consumer demand. The company is very successful at working closely with chemists/pharmacies to increase their sales.

PROSPECTS

  • Wound care is expected to reach LVL1 million by 2015 with a 2% CAGR growth between 2010 and 2015.

CATEGORY DATA

  • Table 102 Sales of Wound Care by Category: Value 2005-2010
  • Table 103 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 104 Wound Care Company Shares 2006-2010
  • Table 105 Wound Care Brand Shares 2007-2010
  • Table 106 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 107 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market Sizes
      • Company Shares
      • Brand Shares
      • Distribution
      • Analysis by Format
      • Analysis by Positioning
      • Analysis by Type
      • Herbal/Traditional vs Standard
      • Pricing

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      RELATED

      Consumer Lifestyle

      Future Demographic

      Country Report